semaglutide depression anxiety GLP-1s linked to lower rates of and than an older anti-obesity drug — not higher. #GLP1 #Semaglutide #Tirzepatide #ObesityMedicine #MentalHealth #Anxiety #Depression #Neuropsychiatry #ObesityTreatment #WeightManagement #Naltrexone Semaglutide may reduce depression, anxiety,

Effects of GLP-1 receptor agonists on bone metabolism in humans Until recently, there were no randomized controlled trials assessing the effects of GLP-1Ra on bone metabolism during the weight loss phase using standard BMD measurement sites (i.e., lumbar spine and proximal femur) [71, 72]

A Call for Balanced Information In the end, were left with a gap between Novo Nordisks message about compounded drugs and the reality of Ozempics own track record

For now, Wegovy remains reserved for those with obesity or qualifying health conditions

Danuglipron Danuglipron is an oral GLP-1RA developed by Pfizer

Interested in learning more about how semaglutide can help you on your weight loss journey